Board of Directors
Meet our Board of Directors and view their biosView Board of Directors
Nicholas Vita co-founded Columbia Care in 2012 and serves as Chief Executive Officer. Nicholas has over 25 years of experience serving in corporate leadership roles, investing capital, structuring and funding public/private partnerships and providing strategic advisory services to Fortune 500 companies throughout the U.S., Europe, Asia and Latin America. Prior to Columbia Care, Nicholas was a Partner and served as the Chairman of the Investment Committee at Apelles Investment Management, LLC, a private investment management company focused on the healthcare and privatized military infrastructure sectors. Before Apelles, Nicholas was a General Partner, member of the Investment Committee, and the Portfolio Manager for the Healthcare Sector at ARX Investment Management. Previously, he worked in the Investment Banking Division at Goldman Sachs & Co. Inc., as an Analyst, Associate and Vice President in the Healthcare Department focused on Mergers, Raid Defense and Corporate Finance. He is a graduate of Columbia College, Columbia University where he was a member of the Men’s Varsity Heavyweight Crew Team.
Michael Abbott co-founded Columbia Care in 2012 and serves as the Executive Chairman. He also serves as Chairman of its’ Board of Directors and sits on its Nominating and Governance Committee. Michael joined Swiss Bank Corporation in 1990 as an Associate in Equity Capital Markets, being transferred to the Bank’s Chicago branch in 1993 to work with SBC O’Connor. In 1996 Michael joined Goldman Sachs as a Vice President in the Convertible Trading and Sales Department. He then led the Structured Product Trading and Origination Group. Michael co-founded the foreign exchange trading hedge fund Elysium Capital in 2002. In 2006 he became Chief Executive Officer and head of the investment committee of Robeco Sage, a multi billion dollar fund of hedge funds. Michael was appointed Chief Investment Officer of the Cornell University endowment in 2010. In 2012 he became a Managing Director at the Raptor Group, a single family office based out of Boston and New York City. Michael started his professional career in 1983 as a London Police Officer and he represented the United Kingdom as a marksman with the British Team throughout the 1980’s, and was the British Police Champion marksmen in 1986. Michael matriculated at King’s College London in their School of Law, graduating in 1990 with a Bachelor of Laws degree. Michael serves on the Advisory Counsel of King’s College London Business School.
Jeff Clarke has been the Executive Chairman of FTD since August 2019. He leads the FTD management team and serves on the company's Board of Directors. Mr. Clarke has more than 30 years of leadership and operational experience. Most recently, Mr. Clarke was the Chief Executive Officer of Eastman Kodak Company from 2014-2019. In addition, Mr. Clarke was Chairman of the Board of Orbitz Worldwide from 2007 to 2014 and Chief Executive Officer of Travelport, Ltd. from 2006 to 2011. From 2004 to 2006, he was the Chief Operating Officer of CA Software and from 2002 to 2003 the Executive Vice President of Hewlett Packard Company. Mr. Clarke was also the Chief Financial Officer of Compaq Computer from 2001 to 2002. He serves on the Board of Directors of Docker, Inc. and California Cyrobank. Mr. Clarke has a Master of Business Administration from Northeastern University, where he currently serves as a Trustee, and a Bachelor's degree in Economics from State University of New York at Geneseo.
Igor Gimelshtein is a Partner at Zola Global, an operationally focused family office that deploys capital to help management teams build lasting and sustainable businesses, primarily in the legal cannabis industry globally. Previously, Mr. Gimelshtein was the Chief Financial Officer and Corporate Secretary of MedReleaf Corp. prior to its acquisition by Aurora Cannabis Inc. in 2018. At MedReleaf, Mr. Gimelshtein provided leadership on financial matters, including capital structure, forecasting, budgeting and reporting, as well as corporate development and data-driven business optimization. Prior to MedReleaf, he was a Vice President at Birch Hill Equity Partners, a leading Canadian private equity firm. Prior to joining Birch Hill, Mr. Gimelshtein worked for Union Square Advisors as an investment banker focused on the technology sector.
In December 2015, James A.C. Kennedy resigned from his role as President and Chief Executive Officer of T. Rowe Price Group, a global investment management organization, serving institutions and individuals around the world and retired from T. Rowe Price in June 2016. Mr. Kennedy spent 38 years with T. Rowe Price, including nine years as CEO, during which time the firm's assets more than doubled to $763 billion. Previously Mr. Kennedy served as an investment analyst, as Director of Research, and as Head of Equities at the firm. Mr. Kennedy also served on the Board of T. Rowe Price for 20 years. Prior to earning his MBA at Stanford University, Mr. Kennedy participated in the Financial Management training program at General Electric. Mr. Kennedy currently serves on the board of United Continental, Downtown Baltimore Partnership and University of Maryland, Baltimore Foundation.
Jonathan May is currently Co-Founder and Managing Director of Floresta Ventures, LLC. Floresta invests, owns and operates restaurant and retail concepts. He is also a co-founder and managing director of Floresta Partners, LLC, a consulting firm focusing on growing multi-unit restaurant and retail concepts. Prior to forming Floresta, Mr. May was Executive Director of Natural Capital Partners Holdings LLC. NCPH works with corporations to measure their environmental impact and deliver solutions for positive impact on carbon, renewable energy, water, biodiversity and communities.
Previously Mr. May was a founder and Managing Director of Catalytic Capital LLC, a private equity firm focused on growing retail and consumer branded companies. Before co-founding Catalytic Capital, Mr. May was Senior Vice President of Corporate Development for Triarc Companies, Inc. where he was responsible for merger identification and execution, corporate finance, and strategic planning. Mr. May also served as Chief Executive Officer of Arby's, Inc., where he managed the growth of 3,400 restaurants comprising $2.5 billion of global system-wide sales. Mr. May held a variety of strategic and operating roles at Arby's before becoming CEO. Mr. May also sits on the Board of Trustees of Griffin Industrial Realty, a publicly traded real estate company. Mr. May formerly was a board member of Sneaker Villa and Marketwatch.com.
Mr. Savage is the Managing Partner of Savage Holdings, LLC, a closely held advisory company which provides advice to U.S. and foreign companies and investment funds.
Mr. Savage has a distinguished career in international banking, venture capital, investment and fund management having held senior positions with some of the major financial institutions in the world including Citibank, where he served in the Middle East and Africa, Equitable Life Assurance Corp. (now AXA Inc.) in the Private Investment Management Department and Alliance Capital Management International as Chairman. Mr. Savage serves as Emeritus Trustee of his graduate alma mater, The Johns Hopkins University, where he served as Chairman of the Advisory Board of The Johns Hopkins Nitze School of Advanced International Studies (SAIS). He is also Chairman Emeritus of Howard University, his undergraduate alma mater. He served as Advisor to Thabo Mbeki, former President of South Africa, and a board member of the New York Academy of Medicine and the Institute of International Finance (IIF). Frank currently serves on the board of directors of Bloomberg L.P. He previously served on the boards of a number of Fortune 500 companies including Lockheed Martin, Inc., Qualcomm Inc., Enron, Alliance Capital Management and Arco Chemical, Inc.
He earned a Bachelor of Arts degree in 1962 from Howard University and a Master’s in International Relations in 1968 from The Johns Hopkins University Nitze School of Advanced International Studies. Mr. Savage holds an Honorary Doctorate Degree